72 related articles for article (PubMed ID: 12489114)
1. Msh2 deficiency increases the mutation frequency in all parts of the mouse colon.
Zhang S; Lloyd R; Bowden G; Glickman BW; de Boer JG
Environ Mol Mutagen; 2002; 40(4):243-50. PubMed ID: 12489114
[TBL] [Abstract][Full Text] [Related]
2. Msh2 DNA mismatch repair gene deficiency and the food-borne mutagen 2-amino-1-methy1-6-phenolimidazo [4,5-b] pyridine (PhIP) synergistically affect mutagenesis in mouse colon.
Zhang S; Lloyd R; Bowden G; Glickman BW; de Boer JG
Oncogene; 2001 Sep; 20(42):6066-72. PubMed ID: 11593414
[TBL] [Abstract][Full Text] [Related]
3. Base transitions dominate the mutational spectrum of a transgenic reporter gene in MSH2 deficient mice.
Andrew SE; Reitmair AH; Fox J; Hsiao L; Francis A; McKinnon M; Mak TW; Jirik FR
Oncogene; 1997 Jul; 15(2):123-9. PubMed ID: 9244348
[TBL] [Abstract][Full Text] [Related]
4. Two mismatch repair gene mutations found in a colon cancer patient--which one is pathogenic?
Kariola R; Otway R; Lönnqvist KE; Raevaara TE; Macrae F; Vos YJ; Kohonen-Corish M; Hofstra RM; Nyström-Lahti M
Hum Genet; 2003 Feb; 112(2):105-9. PubMed ID: 12522549
[TBL] [Abstract][Full Text] [Related]
5. Tumors arising in DNA mismatch repair-deficient mice show a wide variation in mutation frequency as assessed by a transgenic reporter gene.
Baross-Francis A; Milhausen MK; Andrew SE; Jevon G; Jirik FR
Carcinogenesis; 2000 Jun; 21(6):1259-62. PubMed ID: 10837019
[TBL] [Abstract][Full Text] [Related]
6. A636P is associated with early-onset colon cancer in Ashkenazi Jews.
Guillem JG; Rapaport BS; Kirchhoff T; Kolachana P; Nafa K; Glogowski E; Finch R; Huang H; Foulkes WD; Markowitz A; Ellis NA; Offit K
J Am Coll Surg; 2003 Feb; 196(2):222-5. PubMed ID: 12595050
[TBL] [Abstract][Full Text] [Related]
7. Mouse models for hereditary nonpolyposis colorectal cancer.
de Wind N; Dekker M; van Rossum A; van der Valk M; te Riele H
Cancer Res; 1998 Jan; 58(2):248-55. PubMed ID: 9443401
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors.
Kohonen-Corish MR; Daniel JJ; te Riele H; Buffinton GD; Dahlstrom JE
Cancer Res; 2002 Apr; 62(7):2092-7. PubMed ID: 11929830
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of HNPCC-related missense mutations in MSH2.
Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
[TBL] [Abstract][Full Text] [Related]
10. Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes.
Huang RL; Chao CF; Ding DC; Yu CP; Chang CC; Lai HC; Yu MH; Liu HS; Chu TY
Cancer Genet Cytogenet; 2004 Sep; 153(2):108-14. PubMed ID: 15350299
[TBL] [Abstract][Full Text] [Related]
11. A 10-Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred.
Wagner A; van der Klift H; Franken P; Wijnen J; Breukel C; Bezrookove V; Smits R; Kinarsky Y; Barrows A; Franklin B; Lynch J; Lynch H; Fodde R
Genes Chromosomes Cancer; 2002 Sep; 35(1):49-57. PubMed ID: 12203789
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts.
Andrew SE; Xu XS; Baross-Francis A; Narayanan L; Milhausen K; Liskay RM; Jirik FR; Glazer PM
Carcinogenesis; 2000 Jul; 21(7):1291-5. PubMed ID: 10874005
[TBL] [Abstract][Full Text] [Related]
13. Msh-2 suppresses in vivo mutation in a gene dose and lesion dependent manner.
Sansom OJ; Toft NJ; Winton DJ; Clarke AR
Oncogene; 2001 Jun; 20(27):3580-4. PubMed ID: 11429706
[TBL] [Abstract][Full Text] [Related]
14. Evidence for Msh2 haploinsufficiency in mice revealed by MNU-induced sister-chromatid exchange analysis.
Bouffler SD; Hofland N; Cox R; Fodde R
Br J Cancer; 2000 Nov; 83(10):1291-4. PubMed ID: 11044352
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells.
Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N
Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206
[TBL] [Abstract][Full Text] [Related]
16. A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.
Campbell MR; Nation PN; Andrew SE
Cancer Res; 2005 Apr; 65(7):2626-35. PubMed ID: 15805259
[TBL] [Abstract][Full Text] [Related]
17. Methylation tolerance in mismatch repair proficient cells with low MSH2 protein level.
Claij N; Te Riele H
Oncogene; 2002 Apr; 21(18):2873-9. PubMed ID: 11973647
[TBL] [Abstract][Full Text] [Related]
18. Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
Schiemann U; Müller-Koch Y; Gross M; Glas J; Baretton G; Muders M; Mussack T; Holinski-Feder E
Eur J Med Res; 2005 Jan; 10(1):23-8. PubMed ID: 15737950
[TBL] [Abstract][Full Text] [Related]
19. Presymptomatic diagnosis using a deletion of a single codon in families with hereditary non-polyposis colorectal cancer.
Ripa RS; Katballe N; Wikman FP; Jäger AC; Bernstein I; Orntoft T; Schwartz M; Nielsen FC; Bisgaard ML
Mutat Res; 2005 Feb; 570(1):89-96. PubMed ID: 15680406
[TBL] [Abstract][Full Text] [Related]
20. A novel missense germline mutation in exon 2 of the hMSH2 gene in a HNPCC family from Southern Italy.
Baudi F; Fersini G; Lavecchia A; Terracciano R; Leone F; Quaresima B; Faniello MC; De Paola L; Doldo P; Cuda G; Costanzo F; Venuta S
Cancer Lett; 2005 Jun; 223(2):285-91. PubMed ID: 15896463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]